ZYDUS Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS, and when can generic versions of ZYDUS drugs launch?
ZYDUS has three hundred and sixty-eight approved drugs.
There is one US patent protecting ZYDUS drugs. There are twenty-six tentative approvals on ZYDUS drugs.
There are four patent family members on ZYDUS drugs in four countries and nine hundred and fifteen supplementary protection certificates in eighteen countries.
Summary for ZYDUS
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 298 |
| Ingredients: | 289 |
| NDAs: | 368 |
| Patent Litigation for ZYDUS: | See patent lawsuits for ZYDUS |
Drugs and US Patents for ZYDUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | DESOXIMETASONE | desoximetasone | OINTMENT;TOPICAL | 205206-001 | Sep 19, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms Usa | ATENOLOL | atenolol | TABLET;ORAL | 076900-001 | Jan 28, 2005 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | LURASIDONE HYDROCHLORIDE | lurasidone hydrochloride | TABLET;ORAL | 208052-001 | Mar 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
International Patents for ZYDUS Drugs
Supplementary Protection Certificates for ZYDUS Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0914118 | C00914118/01 | Switzerland | ⤷ Sign Up | PRODUCT NAME: DEFERASIROX; REGISTRATION NUMBER/DATE: SWISSMEDIC 57466 03.11.2005 |
| 2316456 | 17C1058 | France | ⤷ Sign Up | PRODUCT NAME: NALTREXONE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER CHLORHYDRATE DE NALTREXONE ET,BUPROPION OU SEL PHARMACEUTIQUEMENT ACCEPTABLE,EN PARTICULIER CHLORHYDRATE DE BUPROPION; REGISTRATION NO/DATE: EU/1/14/988 20150330 |
| 0347066 | 2002C/039 | Belgium | ⤷ Sign Up | PRODUCT NAME: ESCITALOPRAM. OXALAT. (INN) ESCITALOPRAM; NATL. REGISTRATION NO/DATE: 7004 IE10 F 3 20020729; FIRST REGISTRATION: SE 17084 20011207 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
